Research
Canaccord Genuity Downgrades Health Catalyst to Hold From Buy, Adjusts Price Target to $1.80 From $3
Health Catalyst (HCAT) has an average rating of hold and mean price target of $1.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$HCAT
